1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Option (right to buy)
(2)
|
02/15/2005 |
02/14/2012 |
Common shares
|
1,890
|
$
53.625
|
D
|
Â
|
Option (right to buy)
(2)
|
02/15/2005 |
02/14/2012 |
Common shares
|
481
|
$
53.625
|
D
|
Â
|
Option (right to buy)
(3)
|
02/16/2009 |
02/15/2017 |
Common shares
|
1,900
|
$
52.54
|
D
|
Â
|
Option (right to buy)
(3)
|
02/16/2010 |
02/15/2017 |
Common shares
|
1,900
|
$
52.54
|
D
|
Â
|
Option (right to buy)
(3)
|
02/15/2009 |
02/14/2018 |
Common shares
|
1,934
|
$
55.56
|
D
|
Â
|
Option (right to buy)
(3)
|
02/15/2010 |
02/14/2018 |
Common shares
|
1,933
|
$
55.56
|
D
|
Â
|
Option (right to buy)
(3)
|
02/15/2011 |
02/14/2018 |
Common shares
|
1,933
|
$
55.56
|
D
|
Â
|
Option (right to buy)
(3)
|
02/20/2010 |
02/19/2019 |
Common shares
|
4,267
|
$
54.14
|
D
|
Â
|
Option (right to buy)
(3)
|
02/20/2011 |
02/19/2019 |
Common shares
|
4,267
|
$
54.14
|
D
|
Â
|
Option (right to buy)
(3)
|
02/20/2012 |
02/19/2019 |
Common shares
|
4,266
|
$
54.14
|
D
|
Â
|
Option (right to buy)
(4)
|
02/19/2011 |
02/18/2020 |
Common shares
|
3,234
|
$
54.5
|
D
|
Â
|
Option (right to buy)
(4)
|
02/19/2012 |
02/18/2020 |
Common shares
|
3,233
|
$
54.5
|
D
|
Â
|
Option (right to buy)
(4)
|
02/19/2013 |
02/18/2020 |
Common shares
|
3,233
|
$
54.5
|
D
|
Â
|
Option (right to buy)
(4)
|
02/18/2012 |
02/17/2021 |
Common shares
|
3,534
|
$
46.6
|
D
|
Â
|
Option (right to buy)
(4)
|
02/18/2013 |
02/17/2021 |
Common shares
|
3,533
|
$
46.6
|
D
|
Â
|
Option (right to buy)
(4)
|
02/18/2014 |
02/17/2021 |
Common shares
|
3,533
|
$
46.6
|
D
|
Â
|
* |
If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** |
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) |
Balance in the Abbott Laboratories Stock Retirement Trust as of February 1, 2012. |
(2) |
Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. |
(3) |
Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |
(4) |
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |